Patents

Mary Kay Patents Topical Skin Formulations

US Patent No. 10,052,278 B2;  Mary Kay Inc., Addison, TX, has patented a method of treating a human or animal having skin in need of moisturization. The method entails topically applying a composition comprising a hydrolyzed algae extract, a saccharide isomerate, and a dermatologically-acceptable vehicle to the skin, wherein at least one of skin permeability is decreased, filaggrin production is increased, skin moisture is increased, occludin production is increased, or TNFα production is inhibited. The hydrolyzed algae extract comprises exopolysaccharides from Halymenia durvillei, and the saccharide isomerate comprises an exopolysaccharide synthesized by Vibrio alginolyticus. 

Add us as a preferred source on Google

Get the latest Happi news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Happi Newsletters